Cassava Sciences Files 2025 DEF 14A

Ticker: FLNA · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1069530

Cassava Sciences INC DEF 14A Filing Summary
FieldDetail
CompanyCassava Sciences INC (FLNA)
Form TypeDEF 14A
Filed DateApr 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, executive-compensation, corporate-governance

Related Tickers: SAVA

TL;DR

Cassava Sciences (SAVA) filed its 2025 DEF 14A, detailing exec pay and corporate governance.

AI Summary

Cassava Sciences Inc. filed a DEF 14A on April 14, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, formerly known as PAIN THERAPEUTICS INC, is based in Austin, Texas, and operates in the pharmaceutical preparations sector.

Why It Matters

This filing provides crucial information about the compensation of Cassava Sciences' top executives and board members, which can influence investor decisions and perceptions of company management.

Risk Assessment

Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate actions that can significantly impact a company's stock price and investor sentiment.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.

When is the fiscal year end for Cassava Sciences Inc. as reported in this filing?

The fiscal year end for Cassava Sciences Inc. is December 31, 2024.

What was Cassava Sciences Inc. formerly known as?

Cassava Sciences Inc. was formerly known as PAIN THERAPEUTICS INC.

Where is Cassava Sciences Inc. headquartered?

Cassava Sciences Inc. is headquartered in Austin, Texas.

What is the SIC code for Cassava Sciences Inc.?

The Standard Industrial Classification (SIC) code for Cassava Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding CASSAVA SCIENCES INC (FLNA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing